Log in

Kindred Biosciences News Headlines (NASDAQ:KIN)

$9.40
-0.05 (-0.53 %)
(As of 02/20/2020 06:00 AM ET)
Today's Range
$9.39
Now: $9.40
$9.50
50-Day Range
$8.48
MA: $9.43
$10.41
52-Week Range
$5.96
Now: $9.40
$11.35
Volume107,424 shs
Average Volume83,202 shs
Market Capitalization$367.45 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3

Headlines

Kindred Biosciences (NASDAQ KIN) News Headlines

Source:
DateHeadline
Kindred Biosciences Inc (NASDAQ:KIN) Receives Average Recommendation of "Buy" from BrokeragesKindred Biosciences Inc (NASDAQ:KIN) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - February 19 at 6:52 PM
Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health SummitKindred Biosciences to Present at Bank of America Merrill Lynch Animal Health Summit
finance.yahoo.com - February 18 at 9:32 AM
Kindred Biosciences Inc (NASDAQ:KIN) Sees Significant Increase in Short InterestKindred Biosciences Inc (NASDAQ:KIN) Sees Significant Increase in Short Interest
www.americanbankingnews.com - February 12 at 8:45 PM
 Analysts Expect Kindred Biosciences Inc (NASDAQ:KIN) Will Post Quarterly Sales of $1.45 Million Analysts Expect Kindred Biosciences Inc (NASDAQ:KIN) Will Post Quarterly Sales of $1.45 Million
www.americanbankingnews.com - February 11 at 1:06 AM
 Brokerages Anticipate Kindred Biosciences Inc (NASDAQ:KIN) to Announce -$0.38 Earnings Per Share Brokerages Anticipate Kindred Biosciences Inc (NASDAQ:KIN) to Announce -$0.38 Earnings Per Share
www.americanbankingnews.com - February 9 at 10:06 PM
Kindred Biosciences, Inc. Common Stock (KIN) Insider ActivityKindred Biosciences, Inc. Common Stock (KIN) Insider Activity
www.nasdaq.com - February 6 at 11:49 PM
Kindred Biosciences (NASDAQ:KIN) Is Using Debt SafelyKindred Biosciences (NASDAQ:KIN) Is Using Debt Safely
finance.yahoo.com - February 4 at 2:10 PM
BRIEF-Kindred Biosciences Announces Half-Life Extension Tech For Canine AntibodiesBRIEF-Kindred Biosciences Announces Half-Life Extension Tech For Canine Antibodies
www.msn.com - January 8 at 5:12 PM
Exchange Rates for the Fourth Quarter of 2019Exchange Rates for the Fourth Quarter of 2019
finance.yahoo.com - January 7 at 6:37 AM
Is Kindred Biosciences Inc (KIN) A Good Stock To Buy?Is Kindred Biosciences Inc (KIN) A Good Stock To Buy?
finance.yahoo.com - December 24 at 2:09 AM
Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in DogsKindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in Dogs
finance.yahoo.com - December 16 at 12:38 PM
Kindreds Mirataz OKd in EuropeKindred's Mirataz OK'd in Europe
seekingalpha.com - December 12 at 12:53 PM
Kindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing Poor Appetite and Weight LossKindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing Poor Appetite and Weight Loss
finance.yahoo.com - December 12 at 12:53 PM
Should You Worry About Kindred Biosciences, Inc.'s (NASDAQ:KIN) CEO Pay Cheque?Should You Worry About Kindred Biosciences, Inc.'s (NASDAQ:KIN) CEO Pay Cheque?
finance.yahoo.com - December 6 at 2:51 PM
Kindred Bio wins FDA approval of Zimeta for control of equine pyrexiaKindred Bio wins FDA approval of Zimeta for control of equine pyrexia
seekingalpha.com - November 25 at 7:55 PM
Kindred Biosciences Receives FDA Approval of Zimeta™ (dipyrone injection) for the Control of Pyrexia in HorsesKindred Biosciences Receives FDA Approval of Zimeta™ (dipyrone injection) for the Control of Pyrexia in Horses
finance.yahoo.com - November 25 at 7:55 PM
Kindred Biosciences to Participate in Stifel Healthcare Conference and Jefferies London Healthcare ConferenceKindred Biosciences to Participate in Stifel Healthcare Conference and Jefferies London Healthcare Conference
finance.yahoo.com - November 14 at 6:40 PM
Edited Transcript of KIN earnings conference call or presentation 12-Nov-19 9:30pm GMTEdited Transcript of KIN earnings conference call or presentation 12-Nov-19 9:30pm GMT
finance.yahoo.com - November 13 at 12:36 PM
Kindred Biosciences, Inc. (KIN) CEO Richard Chin on Q3 2019 Results - Earnings Call TranscriptKindred Biosciences, Inc. (KIN) CEO Richard Chin on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 12:37 AM
Kindred Biosciences EPS misses by $0.02, misses on revenueKindred Biosciences EPS misses by $0.02, misses on revenue
seekingalpha.com - November 12 at 7:37 PM
Kindred Biosciences Announces Third Quarter 2019 Financial ResultsKindred Biosciences Announces Third Quarter 2019 Financial Results
finance.yahoo.com - November 12 at 7:37 PM
Kindred Biosciences (KIN) Reports Q3 Loss, Lags Revenue EstimatesKindred Biosciences (KIN) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 12 at 7:37 PM
Kindred Biosciences (KIN) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseKindred Biosciences (KIN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
www.nasdaq.com - November 5 at 11:30 PM
Kindred Biosciences (KIN) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseKindred Biosciences (KIN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - November 5 at 1:29 PM
BRIEF-Kindred Biosciences Says Positive Opinion From CVMP In The EU For Mirataz For Cats Experiencing Poor Appetite And Weight LossBRIEF-Kindred Biosciences Says Positive Opinion From CVMP In The EU For Mirataz For Cats Experiencing Poor Appetite And Weight Loss
www.msn.com - October 10 at 11:42 PM
European advisory group backs Kindreds MiratazEuropean advisory group backs Kindred's Mirataz
seekingalpha.com - October 10 at 6:42 PM
Kindred Biosciences Announces Positive Opinion from CVMP in the European Union for Mirataz® (mirtazapine transdermal ointment) for Cats Experiencing Poor Appetite and Weight LossKindred Biosciences Announces Positive Opinion from CVMP in the European Union for Mirataz® (mirtazapine transdermal ointment) for Cats Experiencing Poor Appetite and Weight Loss
finance.yahoo.com - October 10 at 6:42 PM
Kindred Biosciences lines up financingKindred Biosciences lines up financing
seekingalpha.com - October 2 at 5:10 PM
Kindred Biosciences Secures $50 Million Debt Facility with Solar Capital PartnersKindred Biosciences Secures $50 Million Debt Facility with Solar Capital Partners
finance.yahoo.com - October 2 at 7:09 AM
BRIEF-Kindred Biosciences Awarded Contract By The National Cancer Institute In Support Of The Prevent Cancer ProgramBRIEF-Kindred Biosciences Awarded Contract By The National Cancer Institute In Support Of The Prevent Cancer Program
www.msn.com - September 11 at 12:33 AM
Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Lake Street Best Ideas Growth Conference, and Cantor Global Healthcare ConferenceKindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Lake Street Best Ideas Growth Conference, and Cantor Global Healthcare Conference
finance.yahoo.com - August 29 at 10:48 AM
The Kindred Biosciences (NASDAQ:KIN) Share Price Has Gained 88% And Shareholders Are Hoping For MoreThe Kindred Biosciences (NASDAQ:KIN) Share Price Has Gained 88% And Shareholders Are Hoping For More
finance.yahoo.com - August 7 at 5:17 PM
Kindred Biosciences (KIN) CEO Richard Chin on Q2 2019 Results - Earnings Call TranscriptKindred Biosciences' (KIN) CEO Richard Chin on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 2 at 11:53 PM
Kindred Biosciences (KIN) Q2 2019 Earnings Call TranscriptKindred Biosciences (KIN) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 2 at 6:52 PM
Edited Transcript of KIN earnings conference call or presentation 1-Aug-19 8:30pm GMTEdited Transcript of KIN earnings conference call or presentation 1-Aug-19 8:30pm GMT
finance.yahoo.com - August 2 at 9:55 AM
Kindred Biosciences (KIN) Reports Q2 Loss, Lags Revenue EstimatesKindred Biosciences (KIN) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 1 at 10:54 PM
Kindred Biosciences Announces Second Quarter 2019 Financial Results and Unveils Positive Results from Pilot Efficacy Study of Parvovirus Monoclonal AntibodyKindred Biosciences Announces Second Quarter 2019 Financial Results and Unveils Positive Results from Pilot Efficacy Study of Parvovirus Monoclonal Antibody
finance.yahoo.com - August 1 at 5:54 PM
Kindred Bio +12% premarket on positive atopic dermatitis in dogs studyKindred Bio +12% premarket on positive atopic dermatitis in dogs study
seekingalpha.com - July 29 at 6:45 PM
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of its Interleukin-31 Monoclonal Antibody for the Treatment of Atopic Dermatitis in DogsKindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of its Interleukin-31 Monoclonal Antibody for the Treatment of Atopic Dermatitis in Dogs
finance.yahoo.com - July 29 at 8:24 AM
Kindred Biosciences to Announce Second Quarter 2019 Financial ResultsKindred Biosciences to Announce Second Quarter 2019 Financial Results
finance.yahoo.com - July 16 at 10:02 AM
Here’s What Hedge Funds Think About Kindred Biosciences Inc (KIN)Here’s What Hedge Funds Think About Kindred Biosciences Inc (KIN)
finance.yahoo.com - June 29 at 9:35 AM
A Handful of Small Biotechs That Make for Merger ChatterA Handful of Small Biotechs That Make for Merger Chatter
finance.yahoo.com - June 21 at 12:13 PM
Kindred Biosciences to Participate in the B. Riley FBR Institutional Investor Conference, Stifel 2019 Dental & Veterinary Conference and 9th Annual LD Micro InvitationalKindred Biosciences to Participate in the B. Riley FBR Institutional Investor Conference, Stifel 2019 Dental & Veterinary Conference and 9th Annual LD Micro Invitational
finance.yahoo.com - May 13 at 9:49 AM
Kindred Biosciences (KIN) Q1 2019 Earnings Call TranscriptKindred Biosciences (KIN) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 10 at 5:42 PM
Kindred Biosciences (KIN) Reports Q1 Loss, Misses Revenue EstimatesKindred Biosciences (KIN) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 10 at 9:46 AM
Edited Transcript of KIN earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of KIN earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 9:46 AM
Kindred Biosciences Announces First Quarter 2019 Financial ResultsKindred Biosciences Announces First Quarter 2019 Financial Results
www.prnewswire.com - May 9 at 6:09 PM
Kindred Biosciences misses by $0.01, misses on revenueKindred Biosciences misses by $0.01, misses on revenue
seekingalpha.com - May 9 at 6:09 PM
Do Institutions Own Kindred Biosciences, Inc. (NASDAQ:KIN) Shares?Do Institutions Own Kindred Biosciences, Inc. (NASDAQ:KIN) Shares?
finance.yahoo.com - May 7 at 5:50 PM
Kindred Biosciences to Announce First Quarter 2019 Financial ResultsKindred Biosciences to Announce First Quarter 2019 Financial Results
finance.yahoo.com - April 25 at 9:44 AM
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel